Complement Activation and Thrombotic Microangiopathies (original) (raw)

Complement in Secondary Thrombotic Microangiopathy

Kidney International Reports

Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy

Journal of the American Society of Nephrology : JASN, 2015

Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report

Gabriella Guzzo

BMC Nephrology, 2021

View PDFchevron_right

Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab

ALEJANDRA ANDRADE ROSALES

Journal of Immunological Methods, 2016

View PDFchevron_right

The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome

Bruce Berger

The American journal of the medical sciences, 2016

View PDFchevron_right

Atypical hemolytic-uremic syndrome: the interplay between complements and the coagulation system

Arif Asif

Iranian journal of kidney diseases, 2013

View PDFchevron_right

Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

Magdalena Riedl, Damien Noone

Seminars in Thrombosis and Hemostasis, 2014

View PDFchevron_right

Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities

Frank Stifft

Kidney international, 2017

View PDFchevron_right

Too much of a good thing at the site of tissue injury: the instructive example of the complement system predisposing to thrombotic microangiopathy

Patty Atkinson

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2011

View PDFchevron_right

Evaluation of complement regulatory components in patients with atypical hemolytic uremic syndrome

Akbar Dorgalaleh

Central European Journal of Immunology, 2014

View PDFchevron_right

Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome

Eleni Gavriilaki

Experimental Hematology, 2016

View PDFchevron_right

Complement in hemolytic anemia

R. Brodsky

Blood, 2015

View PDFchevron_right

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies

Alejandra Rosales

Frontiers in Pediatrics, 2014

View PDFchevron_right

Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab

Everardo Torres

Medicine, 2017

View PDFchevron_right

Complement activation in thrombotic thrombocytopenic purpura

K. Rázsó, M. Réti

Journal of Thrombosis and Haemostasis, 2012

View PDFchevron_right

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

Fanny Tabarin

Blood, 2013

View PDFchevron_right

Complement Activation During Liver Transplantation—Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome

Arno Nordin

American Journal of Transplantation, 2011

View PDFchevron_right

Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome

Marina Noris

Clinical Journal of the American Society of Nephrology, 2007

View PDFchevron_right

Thrombotic Microangiopathies and the Linkage between von Willebrand Factor and the Alternative Complement Pathway

Jennifer Nolasco

Thrombotic Microangiopathies and the Linkage between von Willebrand Factor and the Alternative Complement Pathway

View PDFchevron_right

Complement component 5 promotes lethal thrombosis

Tomoyuki Okuda

Scientific Reports, 2017

View PDFchevron_right

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Annalisa Perna

American Journal of Kidney Diseases, 2019

View PDFchevron_right

Complement Activation Induces Neutrophil Adhesion and Neutrophil-Platelet Aggregate Formation on Vascular Endothelial Cells

Christoph Licht

Kidney International Reports, 2017

View PDFchevron_right

C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction

Taimoor Ashraf Khan

Case reports in nephrology and dialysis

View PDFchevron_right

ORIGINAL ARTICLE: Human Serum Complement C3 and Factor H in the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count

Elif Ari Bakir

American Journal of Reproductive Immunology, 2009

View PDFchevron_right

Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS

R. Cofiell

Blood, 2015

View PDFchevron_right

Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy

Anne-lie Ståhl

The Journal of Immunology, 2013

View PDFchevron_right

Measurement of complement activation via plasma soluble C5b-9 comparison with terminal complement complex staining in a series of kidney biopsies

Carolyn Wijaya

Kidney and Blood Pressure Research

View PDFchevron_right

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy

Eleni Gavriilaki

Blood Advances, 2017

View PDFchevron_right

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

Ronny Decorte

Proceedings of the National Academy of Sciences, 2003

View PDFchevron_right

Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation

F. Vaziri-Sani

Blood, 2008

View PDFchevron_right

Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin

Kimberley Foley

EBioMedicine, 2016

View PDFchevron_right

Complement Activation and Thrombotic Microangiopathies (original) (raw)

Related papers